Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium oxybate effects on brown adipose tissue activity in narcolepsy type 1
NL-OMON48148Withdrawn
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium oxybate in narcolepsy type 1 (NT1) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Cold-induced brown adipose tissue volume and activity. Planned start Sep 2019; status: withdrawn.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on NL-OMON48148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48148.